Global Chronic Kidney Disease (CKD) Drugs Sales Market Report 2016

December 2016 | 115 pages | ID: G97B28C89C5EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Chronic Kidney Disease (CKD) Drugs

Revenue, means the sales value of Chronic Kidney Disease (CKD) Drugs

This report studies sales (consumption) of Chronic Kidney Disease (CKD) Drugs in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

• Johnson & Johnson
• Abbott Laboratories
• Sanofi
• F. Hoffmann-La Roche
• Takeda Pharmaceuticals
• Actavis
• Akebia Therapeutic
• Raptor Pharmaceuticals
• Rockwell Medical
• AMAG Pharmaceuticals
• Reata Pharmaceuticals
• Cara Therapeutics
• FibroGen

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Chronic Kidney Disease (CKD) Drugs in these regions, from 2011 to 2021 (forecast), like

• United States
• China
• Europe
• Japan

Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Chronic Kidney Disease (CKD) Drugs in each application, can be divided into

• Hospital use
• Clinic use
• Household

Contents

Global Chronic Kidney Disease (CKD) Drugs Sales Market Report 2016

1 CHRONIC KIDNEY DISEASE (CKD) DRUGS OVERVIEW

1.1 Product Overview and Scope of Chronic Kidney Disease (CKD) Drugs
1.2 Classification of Chronic Kidney Disease (CKD) Drugs
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Chronic Kidney Disease (CKD) Drugs
  1.3.1 Hospital use
  1.3.2 Clinic use
  1.3.3 Household
1.4 Chronic Kidney Disease (CKD) Drugs Market by Regions
  1.4.1 United States Status and Prospect (2011-2021)
  1.4.2 China Status and Prospect (2011-2021)
  1.4.3 Europe Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Chronic Kidney Disease (CKD) Drugs (2011-2021)
  1.5.1 Global Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate (2011-2021)
  1.5.2 Global Chronic Kidney Disease (CKD) Drugs Revenue and Growth Rate (2011-2021)

2 GLOBAL CHRONIC KIDNEY DISEASE (CKD) DRUGS COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Global Chronic Kidney Disease (CKD) Drugs Market Competition by Manufacturers
  2.1.1 Global Chronic Kidney Disease (CKD) Drugs Sales and Market Share of Key Manufacturers (2011-2016)
  2.1.2 Global Chronic Kidney Disease (CKD) Drugs Revenue and Share by Manufacturers (2011-2016)
2.2 Global Chronic Kidney Disease (CKD) Drugs (Volume and Value) by Type
  2.2.1 Global Chronic Kidney Disease (CKD) Drugs Sales and Market Share by Type (2011-2016)
  2.2.2 Global Chronic Kidney Disease (CKD) Drugs Revenue and Market Share by Type (2011-2016)
2.3 Global Chronic Kidney Disease (CKD) Drugs (Volume and Value) by Regions
  2.3.1 Global Chronic Kidney Disease (CKD) Drugs Sales and Market Share by Regions (2011-2016)
  2.3.2 Global Chronic Kidney Disease (CKD) Drugs Revenue and Market Share by Regions (2011-2016)
2.4 Global Chronic Kidney Disease (CKD) Drugs (Volume) by Application

3 UNITED STATES CHRONIC KIDNEY DISEASE (CKD) DRUGS (VOLUME, VALUE AND SALES PRICE)

3.1 United States Chronic Kidney Disease (CKD) Drugs Sales and Value (2011-2016)
  3.1.1 United States Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate (2011-2016)
  3.1.2 United States Chronic Kidney Disease (CKD) Drugs Revenue and Growth Rate (2011-2016)
  3.1.3 United States Chronic Kidney Disease (CKD) Drugs Sales Price Trend (2011-2016)
3.2 United States Chronic Kidney Disease (CKD) Drugs Sales and Market Share by Manufacturers
3.3 United States Chronic Kidney Disease (CKD) Drugs Sales and Market Share by Type
3.4 United States Chronic Kidney Disease (CKD) Drugs Sales and Market Share by Application

4 CHINA CHRONIC KIDNEY DISEASE (CKD) DRUGS (VOLUME, VALUE AND SALES PRICE)

4.1 China Chronic Kidney Disease (CKD) Drugs Sales and Value (2011-2016)
  4.1.1 China Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate (2011-2016)
  4.1.2 China Chronic Kidney Disease (CKD) Drugs Revenue and Growth Rate (2011-2016)
  4.1.3 China Chronic Kidney Disease (CKD) Drugs Sales Price Trend (2011-2016)
4.2 China Chronic Kidney Disease (CKD) Drugs Sales and Market Share by Manufacturers
4.3 China Chronic Kidney Disease (CKD) Drugs Sales and Market Share by Type
4.4 China Chronic Kidney Disease (CKD) Drugs Sales and Market Share by Application

5 EUROPE CHRONIC KIDNEY DISEASE (CKD) DRUGS (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Chronic Kidney Disease (CKD) Drugs Sales and Value (2011-2016)
  5.1.1 Europe Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate (2011-2016)
  5.1.2 Europe Chronic Kidney Disease (CKD) Drugs Revenue and Growth Rate (2011-2016)
  5.1.3 Europe Chronic Kidney Disease (CKD) Drugs Sales Price Trend (2011-2016)
5.2 Europe Chronic Kidney Disease (CKD) Drugs Sales and Market Share by Manufacturers
5.3 Europe Chronic Kidney Disease (CKD) Drugs Sales and Market Share by Type
5.4 Europe Chronic Kidney Disease (CKD) Drugs Sales and Market Share by Application

6 JAPAN CHRONIC KIDNEY DISEASE (CKD) DRUGS (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Chronic Kidney Disease (CKD) Drugs Sales and Value (2011-2016)
  6.1.1 Japan Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate (2011-2016)
  6.1.2 Japan Chronic Kidney Disease (CKD) Drugs Revenue and Growth Rate (2011-2016)
  6.1.3 Japan Chronic Kidney Disease (CKD) Drugs Sales Price Trend (2011-2016)
6.2 Japan Chronic Kidney Disease (CKD) Drugs Sales and Market Share by Manufacturers
6.3 Japan Chronic Kidney Disease (CKD) Drugs Sales and Market Share by Type
6.4 Japan Chronic Kidney Disease (CKD) Drugs Sales and Market Share by Application

7 GLOBAL CHRONIC KIDNEY DISEASE (CKD) DRUGS MANUFACTURERS ANALYSIS

7.1 Johnson & Johnson
  7.1.1 Company Basic Information, Manufacturing Base and Competitors
  7.1.2 Chronic Kidney Disease (CKD) Drugs Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 Johnson & Johnson Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.1.4 Main Business/Business Overview
7.2 Abbott Laboratories
  7.2.1 Company Basic Information, Manufacturing Base and Competitors
  7.2.2 115 Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 Abbott Laboratories Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.2.4 Main Business/Business Overview
7.3 Sanofi
  7.3.1 Company Basic Information, Manufacturing Base and Competitors
  7.3.2 137 Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 Sanofi Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.3.4 Main Business/Business Overview
7.4 F. Hoffmann-La Roche
  7.4.1 Company Basic Information, Manufacturing Base and Competitors
  7.4.2 Dec Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 F. Hoffmann-La Roche Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.4.4 Main Business/Business Overview
7.5 Takeda Pharmaceuticals
  7.5.1 Company Basic Information, Manufacturing Base and Competitors
  7.5.2 Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 Takeda Pharmaceuticals Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.5.4 Main Business/Business Overview
7.6 Actavis
  7.6.1 Company Basic Information, Manufacturing Base and Competitors
  7.6.2 Million USD Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 Actavis Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.6.4 Main Business/Business Overview
7.7 Akebia Therapeutic
  7.7.1 Company Basic Information, Manufacturing Base and Competitors
  7.7.2 Pharmaceuticals Product Type, Application and Specification
    7.7.2.1 Type I
    7.7.2.2 Type II
  7.7.3 Akebia Therapeutic Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.7.4 Main Business/Business Overview
7.8 Raptor Pharmaceuticals
  7.8.1 Company Basic Information, Manufacturing Base and Competitors
  7.8.2 Product Type, Application and Specification
    7.8.2.1 Type I
    7.8.2.2 Type II
  7.8.3 Raptor Pharmaceuticals Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.8.4 Main Business/Business Overview
7.9 Rockwell Medical
  7.9.1 Company Basic Information, Manufacturing Base and Competitors
  7.9.2 Product Type, Application and Specification
    7.9.2.1 Type I
    7.9.2.2 Type II
  7.9.3 Rockwell Medical Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.9.4 Main Business/Business Overview
7.10 AMAG Pharmaceuticals
  7.10.1 Company Basic Information, Manufacturing Base and Competitors
  7.10.2 Product Type, Application and Specification
    7.10.2.1 Type I
    7.10.2.2 Type II
  7.10.3 AMAG Pharmaceuticals Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.10.4 Main Business/Business Overview
7.11 Reata Pharmaceuticals
7.12 Cara Therapeutics
7.13 FibroGen

8 CHRONIC KIDNEY DISEASE (CKD) DRUGS MAUFACTURING COST ANALYSIS

8.1 Chronic Kidney Disease (CKD) Drugs Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Process Analysis of Chronic Kidney Disease (CKD) Drugs

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Chronic Kidney Disease (CKD) Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Chronic Kidney Disease (CKD) Drugs Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL CHRONIC KIDNEY DISEASE (CKD) DRUGS MARKET FORECAST (2016-2021)

12.1 Global Chronic Kidney Disease (CKD) Drugs Sales, Revenue Forecast (2016-2021)
12.2 Global Chronic Kidney Disease (CKD) Drugs Sales Forecast by Regions (2016-2021)
12.3 Global Chronic Kidney Disease (CKD) Drugs Sales Forecast by Type (2016-2021)
12.4 Global Chronic Kidney Disease (CKD) Drugs Sales Forecast by Application (2016-2021)

13 APPENDIX

Disclosure Section
Research Methodology
Data Source
China Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Chronic Kidney Disease (CKD) Drugs
Table Classification of Chronic Kidney Disease (CKD) Drugs
Figure Global Sales Market Share of Chronic Kidney Disease (CKD) Drugs by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Applications of Chronic Kidney Disease (CKD) Drugs
Figure Global Sales Market Share of Chronic Kidney Disease (CKD) Drugs by Application in 2015
Figure Hospital use Examples
Figure Clinic use Examples
Figure Household Examples
Figure United States Chronic Kidney Disease (CKD) Drugs Revenue and Growth Rate (2011-2021)
Figure China Chronic Kidney Disease (CKD) Drugs Revenue and Growth Rate (2011-2021)
Figure Europe Chronic Kidney Disease (CKD) Drugs Revenue and Growth Rate (2011-2021)
Figure Japan Chronic Kidney Disease (CKD) Drugs Revenue and Growth Rate (2011-2021)
Figure Global Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate (2011-2021)
Figure Global Chronic Kidney Disease (CKD) Drugs Revenue and Growth Rate (2011-2021)
Table Global Chronic Kidney Disease (CKD) Drugs Sales of Key Manufacturers (2011-2016)
Table Global Chronic Kidney Disease (CKD) Drugs Sales Share by Manufacturers (2011-2016)
Figure 2015 Chronic Kidney Disease (CKD) Drugs Sales Share by Manufacturers
Figure 2016 Chronic Kidney Disease (CKD) Drugs Sales Share by Manufacturers
Table Global Chronic Kidney Disease (CKD) Drugs Revenue by Manufacturers (2011-2016)
Table Global Chronic Kidney Disease (CKD) Drugs Revenue Share by Manufacturers (2011-2016)
Table 2015 Global Chronic Kidney Disease (CKD) Drugs Revenue Share by Manufacturers
Table 2016 Global Chronic Kidney Disease (CKD) Drugs Revenue Share by Manufacturers
Table Global Chronic Kidney Disease (CKD) Drugs Sales and Market Share by Type (2011-2016)
Table Global Chronic Kidney Disease (CKD) Drugs Sales Share by Type (2011-2016)
Figure Sales Market Share of Chronic Kidney Disease (CKD) Drugs by Type (2011-2016)
Figure Global Chronic Kidney Disease (CKD) Drugs Sales Growth Rate by Type (2011-2016)
Table Global Chronic Kidney Disease (CKD) Drugs Revenue and Market Share by Type (2011-2016)
Table Global Chronic Kidney Disease (CKD) Drugs Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Chronic Kidney Disease (CKD) Drugs by Type (2011-2016)
Figure Global Chronic Kidney Disease (CKD) Drugs Revenue Growth Rate by Type (2011-2016)
Table Global Chronic Kidney Disease (CKD) Drugs Sales and Market Share by Regions (2011-2016)
Table Global Chronic Kidney Disease (CKD) Drugs Sales Share by Regions (2011-2016)
Figure Sales Market Share of Chronic Kidney Disease (CKD) Drugs by Regions (2011-2016)
Figure Global Chronic Kidney Disease (CKD) Drugs Sales Growth Rate by Regions (2011-2016)
Table Global Chronic Kidney Disease (CKD) Drugs Revenue and Market Share by Regions (2011-2016)
Table Global Chronic Kidney Disease (CKD) Drugs Revenue Share by Regions (2011-2016)
Figure Revenue Market Share of Chronic Kidney Disease (CKD) Drugs by Regions (2011-2016)
Figure Global Chronic Kidney Disease (CKD) Drugs Revenue Growth Rate by Regions (2011-2016)
Table Global Chronic Kidney Disease (CKD) Drugs Sales and Market Share by Application (2011-2016)
Table Global Chronic Kidney Disease (CKD) Drugs Sales Share by Application (2011-2016)
Figure Sales Market Share of Chronic Kidney Disease (CKD) Drugs by Application (2011-2016)
Figure Global Chronic Kidney Disease (CKD) Drugs Sales Growth Rate by Application (2011-2016)
Figure United States Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate (2011-2016)
Figure United States Chronic Kidney Disease (CKD) Drugs Revenue and Growth Rate (2011-2016)
Figure United States Chronic Kidney Disease (CKD) Drugs Sales Price Trend (2011-2016)
Table United States Chronic Kidney Disease (CKD) Drugs Sales by Manufacturers (2011-2016)
Table United States Chronic Kidney Disease (CKD) Drugs Market Share by Manufacturers (2011-2016)
Table United States Chronic Kidney Disease (CKD) Drugs Sales by Type (2011-2016)
Table United States Chronic Kidney Disease (CKD) Drugs Market Share by Type (2011-2016)
Table United States Chronic Kidney Disease (CKD) Drugs Sales by Application (2011-2016)
Table United States Chronic Kidney Disease (CKD) Drugs Market Share by Application (2011-2016)
Figure China Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate (2011-2016)
Figure China Chronic Kidney Disease (CKD) Drugs Revenue and Growth Rate (2011-2016)
Figure China Chronic Kidney Disease (CKD) Drugs Sales Price Trend (2011-2016)
Table China Chronic Kidney Disease (CKD) Drugs Sales by Manufacturers (2011-2016)
Table China Chronic Kidney Disease (CKD) Drugs Market Share by Manufacturers (2011-2016)
Table China Chronic Kidney Disease (CKD) Drugs Sales by Type (2011-2016)
Table China Chronic Kidney Disease (CKD) Drugs Market Share by Type (2011-2016)
Table China Chronic Kidney Disease (CKD) Drugs Sales by Application (2011-2016)
Table China Chronic Kidney Disease (CKD) Drugs Market Share by Application (2011-2016)
Figure Europe Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate (2011-2016)
Figure Europe Chronic Kidney Disease (CKD) Drugs Revenue and Growth Rate (2011-2016)
Figure Europe Chronic Kidney Disease (CKD) Drugs Sales Price Trend (2011-2016)
Table Europe Chronic Kidney Disease (CKD) Drugs Sales by Manufacturers (2011-2016)
Table Europe Chronic Kidney Disease (CKD) Drugs Market Share by Manufacturers (2011-2016)
Table Europe Chronic Kidney Disease (CKD) Drugs Sales by Type (2011-2016)
Table Europe Chronic Kidney Disease (CKD) Drugs Market Share by Type (2011-2016)
Table Europe Chronic Kidney Disease (CKD) Drugs Sales by Application (2011-2016)
Table Europe Chronic Kidney Disease (CKD) Drugs Market Share by Application (2011-2016)
Figure Japan Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate (2011-2016)
Figure Japan Chronic Kidney Disease (CKD) Drugs Revenue and Growth Rate (2011-2016)
Figure Japan Chronic Kidney Disease (CKD) Drugs Sales Price Trend (2011-2016)
Table Japan Chronic Kidney Disease (CKD) Drugs Sales by Manufacturers (2011-2016)
Table Japan Chronic Kidney Disease (CKD) Drugs Market Share by Manufacturers (2011-2016)
Table Japan Chronic Kidney Disease (CKD) Drugs Sales by Type (2011-2016)
Table Japan Chronic Kidney Disease (CKD) Drugs Market Share by Type (2011-2016)
Table Japan Chronic Kidney Disease (CKD) Drugs Sales by Application (2011-2016)
Table Japan Chronic Kidney Disease (CKD) Drugs Market Share by Application (2011-2016)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Johnson & Johnson Chronic Kidney Disease (CKD) Drugs Global Market Share (2011-2016)
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Abbott Laboratories Chronic Kidney Disease (CKD) Drugs Global Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Sanofi Chronic Kidney Disease (CKD) Drugs Global Market Share (2011-2016)
Table F. Hoffmann-La Roche Basic Information List
Table F. Hoffmann-La Roche Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure F. Hoffmann-La Roche Chronic Kidney Disease (CKD) Drugs Global Market Share (2011-2016)
Table Takeda Pharmaceuticals Basic Information List
Table Takeda Pharmaceuticals Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Takeda Pharmaceuticals Chronic Kidney Disease (CKD) Drugs Global Market Share (2011-2016)
Table Actavis Basic Information List
Table Actavis Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Actavis Chronic Kidney Disease (CKD) Drugs Global Market Share (2011-2016)
Table Akebia Therapeutic Basic Information List
Table Akebia Therapeutic Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Akebia Therapeutic Chronic Kidney Disease (CKD) Drugs Global Market Share (2011-2016)
Table Raptor Pharmaceuticals Basic Information List
Table Raptor Pharmaceuticals Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Raptor Pharmaceuticals Chronic Kidney Disease (CKD) Drugs Global Market Share (2011-2016)
Table Rockwell Medical Basic Information List
Table Rockwell Medical Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Rockwell Medical Chronic Kidney Disease (CKD) Drugs Global Market Share (2011-2016)
Table AMAG Pharmaceuticals Basic Information List
Table AMAG Pharmaceuticals Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure AMAG Pharmaceuticals Chronic Kidney Disease (CKD) Drugs Global Market Share (2011-2016)
Table Reata Pharmaceuticals Basic Information List
Table Reata Pharmaceuticals Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Reata Pharmaceuticals Chronic Kidney Disease (CKD) Drugs Global Market Share (2011-2016)
Table Cara Therapeutics Basic Information List
Table Cara Therapeutics Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Cara Therapeutics Chronic Kidney Disease (CKD) Drugs Global Market Share (2011-2016)
Table FibroGen Basic Information List
Table FibroGen Chronic Kidney Disease (CKD) Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure FibroGen Chronic Kidney Disease (CKD) Drugs Global Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Chronic Kidney Disease (CKD) Drugs
Figure Manufacturing Process Analysis of Chronic Kidney Disease (CKD) Drugs
Figure Chronic Kidney Disease (CKD) Drugs Industrial Chain Analysis
Table Raw Materials Sources of Chronic Kidney Disease (CKD) Drugs Major Manufacturers in 2015
Table Major Buyers of Chronic Kidney Disease (CKD) Drugs
Table Distributors/Traders List
Figure Global Chronic Kidney Disease (CKD) Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Global Chronic Kidney Disease (CKD) Drugs Revenue and Growth Rate Forecast (2016-2021)
Table Global Chronic Kidney Disease (CKD) Drugs Sales Forecast by Regions (2016-2021)
Table Global Chronic Kidney Disease (CKD) Drugs Sales Forecast by Type (2016-2021)
Table Global Chronic Kidney Disease (CKD) Drugs Sales Forecast by Application (2016-2021)